"Epidemiology and Management of Plasma Cell Precursor Diseases: Smoldering Myeloma and Monoclonal Gammopathies of Clinical Significance"

Speaker:

Adeel Khan, M.D., M.P.H., M.S.
Assistant Professor of Internal Medicine, Division of Hematology & Oncology
Director, Myeloma Epidemiology Research
Clinical Director, Monoclonal Gammopathy Precurser Clinic
UT Southwestern Medical Center

About Adeel Khan:

Dr. Khan earned his medical degree with special distinction at the University of Michigan in Ann Arbor, Michigan, while also obtaining a master’s degree in public health from Harvard University. He performed a residency in internal medicine at the Cleveland Clinic and Lerner College of Medicine in Cleveland, Ohio. After serving as a hospitalist at Massachusetts General Hospital and an instructor at Harvard Medical School and concurrently obtaining a master's degree in epidemiology from Columbia University, he gained advanced training in hematology and oncology through a fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. 

Dr. Khan joined the UT Southwestern faculty in 2022.

His research interests include myeloma and other monoclonal gammopathies, as well as cancer epidemiology.